Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| No. 2023AH050848 | Other Grant/Funding Number | Scientific Research Project of Colleges and Universities of Anhui Province |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Objective To examine the therapeutic effect and safety of non-invasive auricular acupoint stimulation application on patients with slow transmission constipation.
Methods In a randomized clinical trial, 60 patients diagnosed with slow transit constipation (STC), ranging in age from 40 to 75 years, were allocated into two distinct cohorts: a study group and a control group. The study group, comprising 30 individuals, received a combination therapy of non-invasive auricular acupoint stimulation and prucapride, while the control group, also consisting of 30 patients, was administered prucapride as a monotherapy. To assess the efficacy of the interventions, various parameters were monitored, including serum levels of Neuropeptide Y (NPY), nitric oxide (NO), fecal water content, and gastrointestinal (GI) transit. The comparative therapeutic outcomes were determined by calculating symptom scores.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| study group | Experimental | The study group, comprising 30 individuals, received a combination therapy of non-invasive auricular acupoint stimulation and prucapride |
|
| control group | Other | also consisting of 30 patients, was administered prucapride as a monotherapy. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Auricular Acupoint Stimulation +prucapride | Other | The study group, comprising 30 individuals, received a combination therapy of non-invasive auricular acupoint stimulation and prucapride |
| Measure | Description | Time Frame |
|---|---|---|
| overall efficacy rate | Symptoms were assessed both one week prior to and one week following treatment. The defecation time (scored as follows: 0 for ≤5 minutes; 1 for >5 to ≤15 minutes; 2 for >15 to ≤25 minutes; and 3 for >25 minutes) and the inter defecation interval (scored as the number of hours divided by 24) were recorded. The efficacy index was calculated using the formula: [(pretreatment score - posttreatment score)/ pretreatment score] × 100%. | From enrollment to the end of treatment at one week |
Not provided
Not provided
Inclusion Criteria: â‘ Conformity to the diagnostic benchmarks for STC as delineated in the Rome IV criteria; â‘¡ Absence of ingestion of any medication influencing gastrointestinal motility within the preceding three months; â‘¢ Provision of informed consent after a comprehensive understanding of the study's objectives; â‘£ An age range of 40 to 75 years.
-
Exclusion Criteria: â‘ Withdrawal from the therapeutic regimen; â‘¡ Auricle or ear canal pathologies; â‘¢ Organic defecation disorder; â‘£ Pregnant or lactating.
-
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Heng Deng, Dr. | Contact | +8613335510159 | tangkun23@outlook.com |
Not provided
Not provided
all IPD collected throughout the trial, only IPD used in the results publication
Not provided
Not provided
Not provided
Not provided
Not provided
slow transmission constipation
Not provided
Not provided
Not provided
Not provided
| prucapride | Drug | was administered prucapride as a monotherapy |
|